QuickView for GW9662 (compound)

1. Differentiating and mature human macrophage expresion profiles in response to LXR activation

1. PPARγ Agonist Rosiglitazone and Antagonist GW9662: Antihypertensive Effects on Chronic Intermittent …
2. Anti-inflammatory effect of covalent PPARγ ligands that have a hybrid structure of GW9662 and a food…
3. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of…
4. The Peroxisome Proliferator-Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamid…
5. Limited Applicability of GW9662 to Elucidate PPARγ-Mediated Fatty Acid Effects in Primary Human T-He…

There were no clinical trials for GW9662